Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery (Q38383345)

2 September 2017

title

Cell surface markers of cancer stem cells: diagnostic macromolecules and targets for drug delivery (English)

1 reference

2 September 2017

1 reference

1 reference

neoplastic stem cells

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Timothy E Andrews

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Dan Wang

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

publication date

1 April 2013

1 reference

Drug delivery and translational research

2 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787981%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

page(s)

121-142

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25787981%20AND%20SRC:MED&resulttype=core&format=json

Will cancer stem cells provide new therapeutic targets?

6 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Stem cell concepts renew cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Stem cells, cancer, and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Potential for therapeutic targeting of tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cells: at the headwaters of tumor development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

A cell initiating human acute myeloid leukaemia after transplantation into SCID mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Extinction models for cancer stem cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cells: the final frontier for glioma virotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Targeting of CD44 eradicates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The chronic myeloid leukemia stem cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cells: a new framework for the design of tumor therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Prospective identification of tumorigenic prostate cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Therapeutics formulated to target cancer stem cells: Is it in our future?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cell markers in common cancers - therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cell subsets and their relationships

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cells in solid tumours: accumulating evidence and unresolved questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cells: cell culture, markers, and targets for new therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cells: problems for therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cell biology: from leukemia to solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

21 January 2018

Global cancer statistics

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Detection of molecular targets on the surface of CD34+/CD38-- stem cells in various myeloid malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD96 is a leukemic stem cell-specific marker in human acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD47 is an adverse prognostic factor and therapeutic antibody target on human acute myeloid leukemia stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cytogenetically aberrant cells are present in the CD34+CD33-38-19- marrow compartment in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Bcr-Abl variants: biological and clinical aspects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Philadelphia chromosome-positive acute lymphoblastic leukemia- current concepts and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD9 correlates with cancer stem cell potentials in human B-acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD90 and CD110 correlate with cancer stem cell potentials in human T-acute lymphoblastic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Breast cancer statistics, 2011.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer stem cells in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Tumor-endothelial interaction links the CD44(+)/CD24(-) phenotype with poor prognosis in early-stage breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD44+/CD24- breast cancer cells exhibit enhanced invasive properties: an early step necessary for metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

In situ identification of putative cancer stem cells by multiplexing ALDH1, CD44, and cytokeratin identifies breast cancer patients with poor prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Isolation and molecular characterization of cancer stem cells in MMTV-Wnt-1 murine breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Co-expression of CD173 (H2) and CD174 (Lewis Y) with CD44 suggests that fucosylated histo-blood group antigens are markers of breast cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Expression of CD176 (Thomsen-Friedenreich antigen) on lung, breast and liver cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification and characterization of cancer initiating cells from BRCA1 related mammary tumors using markers for normal mammary stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Molecular definition of breast tumor heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Phenotypic characterization of human colorectal cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification and expansion of human colon-cancer-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Prognostic significance of the cancer stem cell markers CD133, CD44, and CD166 in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Prognostic impact of the expression of putative cancer stem cell markers CD133, CD166, CD44s, EpCAM, and ALDH1 in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD13 is a therapeutic target in human liver cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Significance of CD90+ cancer stem cells in human liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Wnt/beta-catenin signaling contributes to activation of normal and tumorigenic liver progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

21 January 2018

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

21 January 2018

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

A tumorigenic subpopulation with stem cell properties in melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Melanoma, a tumor based on a mutant stem cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Expression of the stem cell markers nestin and CD133 on circulating melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification and targeting of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Glioblastoma multiforme with very rapid growth and long-term survival in children: report of two cases and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Survival of the fittest: cancer stem cells in therapeutic resistance and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Targeting glioma stem cells: a novel framework for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

A2B5 cells from human glioblastoma have cancer stem cell properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Targeting cancer stem cells through L1CAM suppresses glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Tumour stem cells and drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification and expansion of the tumorigenic lung cancer stem cell population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

21 January 2018

Focus on bladder cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Bladder cancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

New therapies for castration-resistant prostate cancer: efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cell-cell interaction in prostate gene regulation and cytodifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Hierarchical organization of prostate cancer cells in xenograft tumors: the CD44+alpha2beta1+ cell population is enriched in tumor-initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Portrait of PTEN: messages from mutant mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Expression of CD133-1 and CD133-2 in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD24+ cells from hierarchically organized ovarian cancer are enriched in cancer stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification of selective inhibitors of cancer stem cells by high-throughput screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

21 January 2018

AC133/CD133/Prominin-1

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Prominin, a novel microvilli-specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD133 as a marker for cancer stem cells: progresses and concerns

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification of a novel monoclonal antibody recognizing CD133

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Photothermolysis of glioblastoma stem-like cells targeted by carbon nanotubes conjugated with CD133 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

EpCAM in carcinogenesis: the good, the bad or the ugly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Expression of Ep-CAM shifts the state of cadherin-mediated adhesions from strong to weak

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Characterisation of the new EpCAM-specific antibody HO-3: implications for trifunctional antibody immunotherapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Structural and functional characterization of the trifunctional antibody catumaxomab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Mode of cytotoxic action of T cell-engaging BiTE antibody MT110.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The biology of the 17-1A antigen (Ep-CAM)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

A cell-surface molecule involved in organ-specific homing of lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD44 is the principal cell surface receptor for hyaluronate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

A lymphocyte molecule implicated in lymph node homing is a member of the cartilage link protein family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Structure of the regulatory hyaluronan binding domain in the inflammatory leukocyte homing receptor CD44.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Mechanism and biological significance of CD44 cleavage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Regulation of CD44 alternative splicing by SRm160 and its potential role in tumor cell invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification of hyaluronic acid binding sites in the extracellular domain of CD44

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD44 participates in the adhesion of human colorectal carcinoma cells to laminin and type IV collagen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Lymphocyte CD44 binds the COOH-terminal heparin-binding domain of fibronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Cancer cells in transit: the vascular interactions of tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

A novel ligand for CD44 is sulfated proteoglycan

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Analysis of CD44-containing lipid rafts: Recruitment of annexin II and stabilization by the actin cytoskeleton

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Organizing the cell cortex: the role of ERM proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The CD44-initiated pathway of T-cell extravasation uses VLA-4 but not LFA-1 for firm adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Hyaluronan: from extracellular glue to pericellular cue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The biology of cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

New strategies for the treatment of acute myeloid leukemia including antibodies and other novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Bone-marrow haematopoietic-stem-cell niches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

How do stem cells find their way home?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD44 targeting reduces tumour growth and prevents post-chemotherapy relapse of human breast cancers xenografts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The sialoadhesin CD33 is a myeloid-specific inhibitory receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein-tyrosine phosphatases, SHP-1 and SHP-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: engagement of CD33 induces apoptosis of leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Antibody-targeted chemotherapy with immunoconjugates of calicheamicin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Gemtuzumab ozogamicin, a potent and selective anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of drug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Acute myeloid leukemia stem cells and CD33-targeted immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Beyond mere markers: functions for CD34 family of sialomucins in hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Antigen CD34+ marrow cells engraft lethally irradiated baboons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Novel functions of the CD34 family

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The stem cell antigen CD34 functions as a regulator of hemopoietic cell adhesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Binding of L-Selectin to the Vascular Sialomucin CD34

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Hematopoietic stem cell antigen CD34: role in adhesion or homing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Identification of cells initiating human melanomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Aminopeptidase N (CD13) as a target for cancer chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

The structure and main functions of aminopeptidase N.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Bestatin, an aminopeptidase inhibitor with a multi-pharmacological function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Monoclonal antibody-mediated targeting of CD123, IL-3 receptor alpha chain, eliminates human acute myeloid leukemic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Molecular cloning of integrin-associated protein: an immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Integrin-associated protein (CD47) and its ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Paired receptor specificity explained by structures of signal regulatory proteins alone and complexed with CD47

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

CD44 is of Functional Importance for Colorectal Cancer Stem Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Niche retreats for stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13346-012-0075-1

Evaluating therapeutic efficacy against cancer stem cells: new challenges posed by a new paradigm

21 January 2018

1 reference

12 December 2020

Expression of human ABCB5 confers resistance to taxanes and anthracyclines

1 reference

12 December 2020

Immunomonitoring results of a phase II/III study of malignant ascites patients treated with the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3)

1 reference

12 December 2020

Characterization of murine CD34, a marker for hematopoietic progenitor and stem cells

1 reference

12 December 2020

Immunomodulatory and therapeutic properties of bestatin in mice

1 reference

12 December 2020

CD34: structure, biology, and clinical utility.

1 reference

12 December 2020

Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma

1 reference

12 December 2020

BiTE: Teaching antibodies to engage T-cells for cancer therapy

1 reference

12 December 2020

Prevalence estimates for primary brain tumors in the United States by behavior and major histology groups

1 reference

12 December 2020

A CD33-specific single-chain immunotoxin mediates potent apoptosis of cultured human myeloid leukaemia cells

1 reference

12 December 2020

Wnt signaling and cancer

1 reference

12 December 2020

CD133 is a marker of bioenergetic stress in human glioma

1 reference

12 December 2020

CD133 expression is not restricted to stem cells, and both CD133+ and CD133- metastatic colon cancer cells initiate tumors

1 reference

12 December 2020

Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain

1 reference

12 December 2020

Stem cells in normal and leukemic hemopoiesis (Henry Stratton Lecture, 1982).

1 reference

12 December 2020

Expression of normal myeloid-associated antigens by acute leukemia cells

1 reference

12 December 2020

Primitive acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo lack surface expression of c-kit (CD117)

1 reference

12 December 2020

CD133 expression defines a tumor initiating cell population in primary human ovarian cancer

1 reference

12 December 2020

Molecular portraits of intratumoral heterogeneity in human ovarian cancer

1 reference

12 December 2020

Expression of CD133, PAX2, ESA, and GPR30 in invasive ductal breast carcinomas.

1 reference

12 December 2020

Expression of CD44 variant exons in acute myeloid leukemia is more common and more complex than that observed in normal blood, bone marrow or CD34+ cells

1 reference

12 December 2020

Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells

1 reference

12 December 2020

Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines

1 reference

12 December 2020

Distinct patterns of hematopoietic stem cell involvement in acute lymphoblastic leukemia

1 reference

12 December 2020

Clonogenic cells in acute myeloblastic leukemia

1 reference

12 December 2020

Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells

1 reference

12 December 2020

Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.

1 reference

12 December 2020

Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging

1 reference

12 December 2020

Expression of CD133 on leukemia-initiating cells in childhood ALL

1 reference

12 December 2020

Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia

1 reference

12 December 2020

Identification of a cancer stem cell in human brain tumors

1 reference

12 December 2020

Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells

1 reference

12 December 2020

Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.

1 reference

12 December 2020

Cancer stem cells and oncology therapeutics

1 reference

12 December 2020

An anti-CD33 antibody-calicheamicin conjugate for treatment of acute myeloid leukemia. Choice of linker

1 reference

12 December 2020

Bestatin, an inhibitor of aminopeptidase B, produced by actinomycetes

1 reference

12 December 2020

Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas

1 reference

12 December 2020

Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells.

1 reference

12 December 2020

Most acute myeloid leukemia progenitor cells with long-term proliferative ability in vitro and in vivo have the phenotype CD34(+)/CD71(-)/HLA-DR-

1 reference

12 December 2020

Characterization of acute lymphoblastic leukemia progenitor cells

1 reference

12 December 2020

Phase IB study of the EpCAM antibody adecatumumab combined with docetaxel in patients with EpCAM-positive relapsed or refractory advanced-stage breast cancer

1 reference

12 December 2020

Na+/H+ exchanger regulatory factor-1 is a hematopoietic ligand for a subset of the CD34 family of stem cell surface proteins

1 reference

12 December 2020

Functional activity of murine CD34+ and CD34- hematopoietic stem cell populations

1 reference

12 December 2020

A primitive hematopoietic cell is the target for the leukemic transformation in human philadelphia-positive acute lymphoblastic leukemia

1 reference

12 December 2020

Induction of apoptosis by bestatin (ubenimex) in human leukemic cell lines

1 reference

12 December 2020

Flow cytometric analysis of CD123 is useful for immunophenotyping classical Hodgkin lymphoma

1 reference

12 December 2020

Determination of P-glycoprotein, MDR-related protein 1, breast cancer resistance protein, and lung-resistance protein expression in leukemic stem cells of acute myeloid leukemia

1 reference

12 December 2020

Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling

1 reference

12 December 2020

In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment

1 reference

12 December 2020

Lack of expression of Thy-1 (CD90) on acute myeloid leukemia cells with long-term proliferative ability in vitro and in vivo.

1 reference

12 December 2020

Induction of cell cycle entry eliminates human leukemia stem cells in a mouse model of AML.

1 reference

12 December 2020

Development and characterization of immuno-nanocarriers targeting the cancer stem cell marker AC133

1 reference

12 December 2020

Highly Efficient Elimination of Colorectal Tumor-Initiating Cells by an EpCAM/CD3-Bispecific Antibody Engaging Human T Cells

1 reference

12 December 2020

Characterization of a progenitor cell population in childhood T-cell acute lymphoblastic leukemia

1 reference

12 December 2020